Labcorp Earnings Call Signals Growth Despite PAMA Risks
Labcorp Holdings (LH) reported Q3 revenue of $3.8B, up 6.9% YoY, with adjusted EPS at $4.78. The company raised 2026 guidance, citing growth in diagnostics and biopharma services, but noted risks from proposed PAMA reimbursement cuts. Management highlighted strong backlog, productivity savings, and an active acquisition pipeline.




